Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Price-to-Tangible-Book : (As of May. 06, 2024)

View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries Price-to-Tangible-Book?

As of today (2024-05-06), Sun Pharmaceuticals Industries's share price is ₹1511.15. Sun Pharmaceuticals Industries's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was ₹0.00. Hence, Sun Pharmaceuticals Industries's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Sun Pharmaceuticals Industries's Price-to-Tangible-Book or its related term are showing as below:

NSE:SUNPHARMA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.61 Med: 5.6 Max: 9.91
Current: 8.63

During the past 13 years, Sun Pharmaceuticals Industries's highest Price to Tangible Book Ratio was 9.91. The lowest was 2.61. And the median was 5.60.

NSE:SUNPHARMA's Price-to-Tangible-Book is ranked worse than
88.63% of 871 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs NSE:SUNPHARMA: 8.63

A closely related ratio is called PB Ratio. As of today, Sun Pharmaceuticals Industries's share price is ₹1511.15. Sun Pharmaceuticals Industries's Book Value per Sharefor the quarter that ended in Dec. 2023 was ₹0.00. Hence, Sun Pharmaceuticals Industries's P/B Ratio of today is .

Sun Pharmaceuticals Industries Price-to-Tangible-Book Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Price-to-Tangible-Book Chart

Sun Pharmaceuticals Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.95

2.61

4.16

6.19

5.52

Sun Pharmaceuticals Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	5.52	-	6.61	-

Competitive Comparison of Sun Pharmaceuticals Industries's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharmaceuticals Industries's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Price-to-Tangible-Book falls into.

Sun Pharmaceuticals Industries Price-to-Tangible-Book Calculation

Sun Pharmaceuticals Industries's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1511.15	/	0
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Sun Pharmaceuticals Industries Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » Price-to-Tangible-Book

Traded in Other Exchanges

524715:India

Address

Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063

Website

https://www.sunpharma.com

Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines

No Headlines